For more information on eligibility requirements, you can call 1-800-LillyRx ( 1-800-545-5979 ) or visit www.zepbound.lilly.com
*Note: This is NOT a complete list and we have not used any branded names as new drugs are released so frequently that it is not possible to keep up
While the results of the study cover the three broad indications of weight loss management, diabetes and secondary prevention of cardiovascular disease, there were a few key criteria that were excluded from the study
Not recommended for individuals with tumors or melanoma
However, the inclusion of GIP in Tirzepatide provides a broader impact on blood sugar regulation compared to Semaglutide, which acts solely through the GLP-1 pathway
Injectable Tirzepatide Overview: Tirzepatide is a newer injectable medication that activates both GLP-1 and GIP receptors, offering a dual hormonal approach to diabetes management and weight loss